Allogeneic Umbilical Cord Blood Therapy for Chronic TBI

Summary

This open label trial is conducted to investigate the efficacy and safety of umbilical cord blood therapy for chronic traumatic brain injury patients. The study hypothesis is that the participants will show significant improvement in cognition and function after Umbilical cord blood (UCB) transplantation.

Timeline

Start

2014-07

Primary completion

2015-12

Completion

2015-12

Drugs

Indications